The Department of Endocrinology, 
Canagliflozin/metformin Fixed-dose Combination: National Evidence, Global Relevance.
- Endocrinologist, Department of Endocrinology, Bharti Hospital, Karnal, Haryana
- University Center for Research & Development, Chandigarh University, Punjab, India, Corresponding Author.
- Professor, Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, Tamil Nadu, India
- Honorary Scientist, Non Communicable Disease Unit, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
The Journal of the Association of Physicians of India Vol. 72 · Issue 4 · pp. 11
PMID 38881076DOI 10.59556/japi.72.0473
Cite This Article
Sanjay Kalra, Nitin Kapoor. Canagliflozin/metformin Fixed-dose Combination: National Evidence, Global Relevance. The Journal of the Association of Physicians of India. 2024;72(4):11. doi:10.59556/japi.72.0473
Keywords
- Humans
- Canagliflozin
- Metformin
- Hypoglycemic Agents
- Diabetes Mellitus
- Type 2
- Drug Combinations
- Sodium-Glucose Transporter 2 Inhibitors
